Aileron Therapeutics, Inc. (ALRN): Price and Financial Metrics
ALRN Price/Volume Stats
| Current price | $2.11 | 52-week high | $7.42 |
| Prev. close | $1.93 | 52-week low | $1.61 |
| Day low | $1.96 | Volume | 63,300 |
| Day high | $2.17 | Avg. volume | 64,833 |
| 50-day MA | $2.70 | Dividend yield | N/A |
| 200-day MA | $3.28 | Market Cap | 45.72M |
ALRN Stock Price Chart Interactive Chart >
Aileron Therapeutics, Inc. (ALRN) Company Bio
Aileron Therapeutics is a clinical-stage biopharmaceutical company advancing a novel class of therapeutics called stapled peptides, which represent the first general solution, or "scaffold" for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. The company's lead product candidate ALRN-6924 is being evaluated in multiple clinical trials. The company was founded in 2005 and is based in Cambridge, Massachusetts.
ALRN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ALRN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | -4.09% |
| 1-year | -35.87% |
| 3-year | 386.96% |
| 5-year | 77.31% |
| YTD | -8.26% |
| 2024 | -24.56% |
| 2023 | 28.63% |
| 2022 | 321.03% |
| 2021 | -45.88% |
| 2020 | 81.50% |